参松养心胶囊治疗冠心病疗效探讨

The Effects of Shengsongyangxin Capsule in Treating Patients of Coronary Disease

目的探讨参松养心胶囊在冠心病治疗中的临床疗效。方法收集2012年6月—2013年12月该院收治的冠心病患者76例,分为2组,各38例。对照组采用西药进行常规治疗。观察组在此基础上给予中药参松养心胶囊治疗,观察两组心电图疗效、心绞痛疗效及对微循环功能的影响。结果心电图:对照组痊愈8例,有效15例,无效15例,总有效率60.52%。观察组痊愈14例,有效18例,无效6例,总有效率84.21%,两组比较差异有统计学意义(P<0.05)。心绞痛:对照组痊愈6例,有效13例,无效20例,总有效率47.37%。观察组痊愈15例,有效16例,无效7例,总有效率81.57%,两组比较差异有统计学意义(P<0.05)。有效观察组治疗后对微循环改善情况明显高于对照组,有显著性差异(P<0.05)。结论参松养心胶囊联合西药治疗冠心病临床疗效显著,具有重要的临床价值。

[Abastract]Objective To study the clinical efficiency of Shensongyangxin capsule in treatment of coronary disease.Methods 76 patients with coronary heart disease were randomly divided into two groups with 38 cases in each.The control group used routine treatment of Western Medicine.The patients in observation group were given Shensongyangxin capsule based on the routine treatment. Observation two groups of electrocardiogram curative effect and effects on micro circulation function.Results ECG： The control group has 8 cases recovery,15 coses effective, 15 cases invalid, total effective rate was 60.52%, Observation group has 14 cases recovery,18 coses effective, 6 cases invalid, total effective rate was 84.21%. The differences of two groups were statistically significant（P〈0.05）. Angina pectoris： The control group has 6 cases recovery,13 coses effective, 20 cases invalid, total effective rate was 47.37%, Observation group has 15 cases recovery,16 coses effective, 7 cases invalid, total effective rate was 81.57%. The differences of two groups were statistically significant（P〈0.05）. After treatment,both the results of electrocardiogram and microcirculation were better than those in the control group.The differences were statistically significant（P〈0.05）.Conclusion The effects of Shensongyangxin capsule were remarkable in the treatment of coronary disease, so it has important clinical value.